Abstract
The expressions of cyclin D1, cyclin E, cyclin-dependent kinase 4 (CDK4), and CDK2 were immunohistochemically examined in 90 patients with human oesophageal squamous cell carcinoma (SCC) to determine their relationship to the tumour behaviour and patient prognosis. Nuclear immunostaining of cyclin D1 and cyclin E was observed in 28 (31.1%) and 27 tumours (30.0%) respectively. Thirty-nine tumours (43.3%) and 31 tumours (34.4%) exhibited both cytoplasmic and nuclear positivity for CDK4 and CDK2 respectively. Of 28 cyclin D1-positive and 27 cyclin E-positive tumours, CDK4 was overexpressed in 12 (42.8%) tumours and CDK2 in seven (25.9%) tumours respectively. There was no significant relationship in immunopositivity between cyclin D1 and CDK4 or between cyclin E and CDK2. Simultaneous immunoreactivity for both cyclin D1 and CDK4 was significantly associated with venous invasion (P < 0.05). In a univariate analysis, the prognosis of patients with tumours that were both cyclin D1- and CDK4-positive was significantly poorer than that of patients with cyclin D1-negative tumours (P < 0.05). In a multivariate analysis, both cyclin D1 and CDK4 immunoreactivities (P < 0.01) and tumour stage (P < 0.001) were recognized as independent risk factors. In this analysis, the hazard ratio for cyclin D1-positive and CDK4-negative cases compared with cyclin D1-negative cases was significant (hazard ratio = 3.128, 95% confidence interval = 1.418–6.899, P = 0.0047). No significant prognostic relevance was detected in both cyclin E and CDK2 immunoreactivity. Our in vivo findings suggest that in human oesophageal SCC, cyclin D1 and cyclin E and their functional partners, CDK4 and CDK2, often exhibit dysregulated overexpression in many cases, and that tumours with simultaneous expression of cyclin D1 and CDK4 are frequently associated with venous invasion and have a worse prognosis, statistically. Moreover, overexpression of cyclin D1 alone may also contribute to tumour progression independent of CDK4 overexpression.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Asano, K., Sakamoto, H., Sasaki, H., Ochiya, T., Yoshida, T., Ohishi, Y., Machida, T., Kakizoe, T., Sugimura, T. & Terada, M. (1995) Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Biochem Biophys Res Commun 217: 1169–1176.
Bartkova, J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A. F., Zeuthen, J. & Bartek, J. (1996) The p16-cyclin D/Cdk4-pRB pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res 56: 5475–5483.
Dirks, P. B., Hubbard, S. L., Murakami, M. & Rutka, J. T. (1997) Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines. J Neuropathol Exp Neurol 56: 291–300.
Doki, Y., Imoto, M., Han, E. K. H., Sgambato, A. & Weinstein, I. B. (1997) Increased expression of the p27kip1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis 18: 1139–1148.
Furihata, M., Ohtsuki, Y., Ogoshi, S., Takahashi, A., Tamiya, T. & Ogata, T. (1993) Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 54: 226–230.
Furihata, M., Ishikawa, T., Inoue, A., Yoshikawa, C., Sonobe, H., Ohtsuki, Y., Araki, K. & Ogoshi, S. (1996) Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2: 1781–1785.
Igaki, H., Sasaki, H., Kishi, T., Sakamoto, H., Tachimori, Y., Kato, H., Watanabe, H., Sugimura, T. & Terada, M. (1994) Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell lines. Biochem Biophys Res Commun 203: 1090–1095.
Ishikawa, T., Furihata, M., Ohtsuki, Y., Ono, H., Inoue, A. & Ogoshi, S. (1997) Aberrant expression of p53 and retinoblastoma gene products in human esophageal squamous cell carcinoma. Int J Oncol 11: 1109–1114.
Ishikawa, T., Furihata, M., Ohtsuki, Y., Murakami, H., Inoue, A. & Ogoshi, S. (1998) Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human esophageal squamous cell carcinoma. Br J Cancer 77: 92–97.
Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R. & Weinstein, I. B. (1993) Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci USA 90: 9026–9030.
Khatib, Z. A., Matsushime, H., Valentine, M., Shapiro, D. N., Sherr, C. J. & Look, A. T. (1993) Co-amplification of the CDK4 gene with MDM2 and GLI in human sarcomas. Cancer Res 53: 5535–5541.
Lee, M. H., Reynisdottir, I. & Massague, J. (1995) Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9: 639–649.
Marone, M., Scambia, G., Giannitelli, C., Ferrandina, G., Masciullo, V., Bellacosa, A., Benedetti Panici, P. & Mancuso, S. (1998) Analysis of cyclin E and cdk2 in ovarian cancer: gene amplification and RNA overexpression. Int J Cancer 75: 34–39.
Masciullo, V., Scambia, G., Marone, M., Giannitelli, C., Ferrandina, G., Bellacosa, A., Benedetti Panici, P. & Mancuso, S. (1997) Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas. Int J Cancer 74: 390–395.
Motokura, T. & Arnold, A. (1993) Cyclin D1 and oncogenesis. Curr Opin Genet Dev 3: 5–10.
Naitoh, H., Shibata, J., Kawaguchi, A., Kodama, M. & Hattori, T. (1995) Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146: 1161–1169.
Nakamura, T., Sanokawa, R., Sasaki, Y. F., Ayusawa, D., Oishi, M. & Mori, N. (1995) Cyclin I: A new cyclin encoded by a gene isolated from human brain. Exp Cell Res 221: 534–542.
Neuman, E., Ladha, M. H., Lin, N., Upton, T. M., Miller, S. J., Direnzo, J., Pestell, R. G., Hinds, P. W., Dowdy, S. F., Brown, M. & Ewen, M. E. (1997) Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol 17: 5538–5347.
Sherr, C. J. (1993) Mammalian G1 cyclins. Cell 73: 1059–1065.
Sherr, C. J. (1994) G1 phase progression: cyclins on cue. Cell 79: 551–555.
Sherr, C. J. (1996) Cancer cell cycles. Science 274: 1672–1677.
Sheyn, I., Noffsinger, A. E. & Heffelfinger, S. (1997) Amplification and expression of the cyclin D1 gene in anal and esophageal carcinomas. Hum Pathol 28: 270–276.
Tominaga, O., Nita, M. E., Nagawa, H., Fujii, S., Tsuruo, T. & Muto, T. (1997) Expressions of cell cycle regulators in human colorectal cancer cell lines. Jpn J Cancer Res 88: 855–860.
Tsuruta, H., Sakamoto, H., Onda, M. & Terada, M. (1993) Amplification and overexpression of EXP1 and EXP2/cyclin D1 genes in human esophageal carcinomas. Biochem Biophys Res Commun 196: 1529–1536.
Wang, L. D., Shi, S. T., Zhou, Q., Goldstein, S., Hong, J. Y., Shao, P., Qiu, S. L. & Yang, C. S. (1994) Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer 59: 514–519.
Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
Zhang, T., Nanney, L. B., Luongo, C., Lamps, L., Heppner, K. J., DuBois, R. N. & Beauchamp, R. D. (1997) Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (CDK4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res 57: 169–175.
Zhou, P., Jiang, W., Weghorst, C. M. & Weinstein, I. B. (1996) Overexpression of cyclin D1 enhances gene amplification. Cancer Res 56: 36–39.
Zwijsen, R. M., Wientjens, E., Klompmaker, R., van der Sman, D., Bernards, R. & Michalides, R. J. (1997) CDK-independent activation of estrogen receptor by cyclin D1. Cell 88: 405–415.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Matsumoto, M., Furihata, M., Ishikawa, T. et al. Comparison of deregulated expression of cyclin D1 and cyclin E with that of cyclin-dependent kinase 4 (CDK4) and CDK2 in human oesophageal squamous cell carcinoma. Br J Cancer 80, 256–261 (1999). https://doi.org/10.1038/sj.bjc.6690348
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690348
Keywords
This article is cited by
-
The Role of Glycogen Synthase Kinase 3-β in Immunity and Cell Cycle: Implications in Esophageal Cancer
Archivum Immunologiae et Therapiae Experimentalis (2014)
-
CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis
Nature Medicine (2002)